Evidence map›Paper›PMID 37100486›Full record

ArticleJournal of the American College of Cardiology2023

Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial.

Dan D Nguyen, John A Spertus, Karen P Alexander, Jonathan D Newman, John A Dodson, Philip G Jones, Susanna R Stevens, Sean M O'Brien, Reto Gamma, Gian P Perna and 19 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01471522 (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
10.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01471522 nacompletednot on this map

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

TypeinterventionalSponsorNYU Langone HealthRan2012 to 2023Enrolled5,179ConditionsCardiovascular Diseases, Coronary Disease, Coronary Artery Disease, Heart DiseasesArmscardiac catheterization, coronary artery bypass graft surgery, percutaneous coronary intervention, Lifestyle, Medication
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Characterizing heterogeneity in health-related quality of life trajectories in coronary artery disease: a longitudinal latent Markov analysis.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Chronic Coronary Disease in Older Adults.The Medical clinics of North America · 2024
    Review
  14. Review
  15. Imaging Advances in Heart Failure.Cardiac failure review · 2024
    Review
  16. Stable Coronary Artery Disease in the Age of Geriatric Cardiology.Journal of the American College of Cardiology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 14 institutions in 8 countries.

Dan D NguyenSaint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri-Kansas City, Kansas City, Missouri, USA. Electronic address: dannguyen1@saintlukeskc.org.
John A SpertusSaint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri-Kansas City, Kansas City, Missouri, USA.
Karen P AlexanderDuke Clnical Research Institute, Durham, North Carolina, USA.
Jonathan D NewmanNew York University Grossman School of Medicine, New York, New York, USA.
John A DodsonNew York University Grossman School of Medicine, New York, New York, USA.
Philip G JonesSaint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri-Kansas City, Kansas City, Missouri, USA.
Susanna R StevensDuke Clnical Research Institute, Durham, North Carolina, USA.
Sean M O'BrienDuke Clnical Research Institute, Durham, North Carolina, USA.
Reto GammaDepartment of Cardiology, Swiss Cardiovascular Centre, University Hospital Inselspital, Bern, Switzerland.
Gian P PernaDepartment of Cardiology, Ospedali Riuniti Ancona, Ancona, Italy.
Pallav GargLondon Health Sciences Centre, London, Ontario, Canada.
João V VitolaQuanta Diagnostico, Curitiba, Brazil.
Benjamin J W ChowUniversity of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Andras VertesDél-pesti Centrumkóház Hospital, National Institute of Hematology and Infectious Disease, Cardiovascular Department, Budapest, Hungary.
Harvey D WhiteGreen Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand; University of Auckland, Auckland, New Zealand.
Paola E P SmanioInstituto Dante Pazzanese de Cardiologia e Fleury Medicina e Saúde, São Paulo, Brazil.
Roxy SeniorDepartment of Medicine, Northwick Park Hospital-Royal Brompton Hospital, London, United Kingdom.
Claes HeldDepartment of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala, Sweden.
Jianghao LiDuke Clnical Research Institute, Durham, North Carolina, USA.
William E BodenVeteran Affairs, New England Healthcare System, Boston, Massachusetts, USA.
Daniel B MarkDuke Clnical Research Institute, Durham, North Carolina, USA.
Harmony R ReynoldsNew York University Grossman School of Medicine, New York, New York, USA.
Sripal BangaloreNew York University Grossman School of Medicine, New York, New York, USA.
Paul S ChanSaint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri-Kansas City, Kansas City, Missouri, USA.
Gregg W StoneThe Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Cardiovascular Research Foundation, New York, New York, USA.
Suzanne V ArnoldSaint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri-Kansas City, Kansas City, Missouri, USA.
David J MaronDepartment of Medicine, Stanford University, Palo Alto, California, USA.
Judith S HochmanNew York University Grossman School of Medicine, New York, New York, USA.
ISCHEMIA Research Group
New York University · USSaint Luke's Health System · USCardiovascular Institute of the South · USInstituto Dante Pazzanese de Cardiologia · BRLondon Health Sciences Centre · CANorthwick Park Hospital · GBOspedali Riuniti di Ancona · ITSaint Luke's Hospital · USStanford University · USUniversity Hospital of Bern · CHUniversity of Auckland · NZUniversity of Ottawa · CAUppsala University · SEVA New England Healthcare System · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
The Ischemia Trial - CCCU01HL105907 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HOCHMAN, JUDITH S · 2011 to 2019
$100.1M
The ISCHEMIA Trial - SDCCU01HL105462 · NHLBI · DUKE UNIVERSITY · PI ALEXANDER, KAREN P, O'BRIEN, SEAN M · 2011 to 2019
$17.8M
THE ISCHEMIA TRIAL - IICCU01HL105561 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SHAW, LESLEE J · 2011 to 2018
$6.5M
CARDIOVASCULAR OUTCOMES RESEARCH TRAINING PROGRAMT32HL110837 · NHLBI · UNIVERSITY OF MISSOURI KANSAS CITY · PI JOHN A SPERTUS · 2012 to 2026
$5.0M
The ISCHEMIA Trial - EQOLU01HL105565 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2011 to 2017
$2.4M
NCATS NIH HHS UL1 TR001445NCATS NIH HHS UL1 TR002243NHLBI NIH HHS T32 HL110837NHLBI NIH HHS U01 HL105462NHLBI NIH HHS U01 HL105561NHLBI NIH HHS U01 HL105565NHLBI NIH HHS U01 HL105907
6 · The paper itself

Abstract

backgroundWhether initial invasive management in older vs younger adults with chronic coronary disease and moderate or severe ischemia improves health status or clinical outcomes is unknown.

objectivesThe goal of this study was to examine the impact of age on health status and clinical outcomes with invasive vs conservative management in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial.

methodsOne-year angina-specific health status was assessed with the 7-item Seattle Angina Questionnaire (SAQ) (score range 0-100; higher scores indicate better health status). Cox proportional hazards models estimated the treatment effect of invasive vs conservative management as a function of age on the composite clinical outcome of cardiovascular death, myocardial infarction, or hospitalization for resuscitated cardiac arrest, unstable angina, or heart failure.

resultsAmong 4,617 participants, 2,239 (48.5%) were aged <65 years, 1,713 (37.1%) were aged 65 to 74 years, and 665 (14.4%) were aged ≥75 years. Baseline SAQ summary scores were lower in participants aged <65 years. Fully adjusted differences in 1-year SAQ summary scores (invasive minus conservative) were 4.90 (95% CI: 3.56-6.24) at age 55 years, 3.48 (95% CI: 2.40-4.57) at age 65 years, and 2.13 (95% CI: 0.75-3.51) at age 75 years (P

conclusionsOlder patients with chronic coronary disease and moderate or severe ischemia had consistent improvement in angina frequency but less improvement in angina-related health status with invasive management compared with younger patients. Invasive management was not associated with improved clinical outcomes in older or younger patients. (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches [ISCHEMIA]; NCT01471522).

Indexed as

Coronary DiseaseMyocardial InfarctionAgedAngina PectorisChronic DiseaseHealth StatusHumansMiddle AgedMyocardial RevascularizationQuality of LifeTreatment Outcomecoronary artery diseaseolder adultsquality of life

Identifiers

PMID37100486
PMCPMC10902923
OpenAlexW4366818916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.